02-Jul-2020 - Merck KGaA

Merck acquires a French company

Merck Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition

Merck enhanced its advanced bioprocess portfolio through the acquisition of RESOLUTION Spectra Systems, a Meylan, France-based leader in bioprocess analytical monitoring. The company offers Raman spectroscopy analysis through its GMP-ready instrumentation and software. Financial details of the acquisition were not disclosed.

“This acquisition supports our vision of delivering intensified, connected and continuous bioprocessing,” said Andrew Bulpin, head of Process Solutions, Life Science, at Merck. “Raman measurement technology, coupled with the software to analyze and manage the generated data, allows us to offer unique and integrated solutions to help our customers optimize their bioprocesses.”

Christophe Bonneville, co-founder of RESOLUTION Spectra Systems, added, “This acquisition validates our common strategy to support Process Analytical Technology implementation as a key element of biopharmaceutical industry digitalization.”

The acquisition of RESOLUTION Spectra Systems enhances Merck’s ability to provide advanced process analytical technologies across its bioprocess portfolio, another critical step toward enabling the biomanufacturing facility of the future.

Facts, background information, dossiers
More about Merck